Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ)
CNY 77.66
(-1.03%)
CNY 77.66
(-1.03%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -389.32 Million CNY | 22.39% |
| 2022 | -501.64 Million CNY | 12.77% |
| 2021 | -575.08 Million CNY | -1444.24% |
| 2020 | 42.78 Million CNY | 6.85% |
| 2019 | 40.03 Million CNY | 85.11% |
| 2018 | 21.62 Million CNY | -21.96% |
| 2017 | 27.71 Million CNY | 59.38% |
| 2016 | 17.38 Million CNY | -83.77% |
| 2015 | 107.16 Million CNY | -20.09% |
| 2014 | 134.1 Million CNY | 82.01% |
| 2013 | 73.67 Million CNY | 288.95% |
| 2012 | -38.99 Million CNY | 59.62% |
| 2011 | -96.55 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -263.71 Million CNY | -139.53% |
| 2024 Q1 | -458.04 Million CNY | -17.65% |
| 2024 Q2 | -110.09 Million CNY | 75.96% |
| 2023 Q3 | -363.55 Million CNY | 1.96% |
| 2023 Q4 | -389.32 Million CNY | -7.09% |
| 2023 FY | -389.32 Million CNY | 22.39% |
| 2023 Q1 | -472.35 Million CNY | 5.84% |
| 2023 Q2 | -370.83 Million CNY | 21.49% |
| 2022 Q3 | -497.36 Million CNY | -10.67% |
| 2022 Q2 | -449.42 Million CNY | 27.91% |
| 2022 Q1 | -623.39 Million CNY | -8.4% |
| 2022 Q4 | -501.64 Million CNY | -0.86% |
| 2022 FY | -501.64 Million CNY | 12.77% |
| 2021 Q2 | 50.36 Million CNY | 2.36% |
| 2021 Q4 | -575.08 Million CNY | -828.11% |
| 2021 Q1 | 49.2 Million CNY | 15.01% |
| 2021 FY | -575.08 Million CNY | -1444.24% |
| 2021 Q3 | -61.96 Million CNY | -223.03% |
| 2020 Q4 | 42.78 Million CNY | -28.06% |
| 2020 FY | 42.78 Million CNY | 6.85% |
| 2020 Q2 | 79.1 Million CNY | 18.44% |
| 2020 Q1 | 66.79 Million CNY | 66.82% |
| 2020 Q3 | 59.47 Million CNY | -24.82% |
| 2019 Q2 | 34.33 Million CNY | 63.91% |
| 2019 FY | 40.03 Million CNY | 85.11% |
| 2019 Q1 | 20.94 Million CNY | -3.14% |
| 2019 Q4 | 40.03 Million CNY | -5.63% |
| 2019 Q3 | 42.42 Million CNY | 23.55% |
| 2018 Q1 | 23.47 Million CNY | -15.28% |
| 2018 Q4 | 21.62 Million CNY | -29.95% |
| 2018 FY | 21.62 Million CNY | -21.96% |
| 2018 Q3 | 30.87 Million CNY | 59.73% |
| 2018 Q2 | 19.32 Million CNY | -17.68% |
| 2017 Q2 | 29.7 Million CNY | 187.74% |
| 2017 Q3 | 28.46 Million CNY | -4.18% |
| 2017 Q4 | 27.71 Million CNY | -2.63% |
| 2017 FY | 27.71 Million CNY | 59.38% |
| 2017 Q1 | 10.32 Million CNY | -40.63% |
| 2016 Q1 | 10.83 Million CNY | 0.0% |
| 2016 FY | 17.38 Million CNY | -83.77% |
| 2016 Q4 | 17.38 Million CNY | -79.7% |
| 2016 Q3 | 85.65 Million CNY | -3.67% |
| 2016 Q2 | 88.91 Million CNY | 720.92% |
| 2015 FY | 107.16 Million CNY | -20.09% |
| 2014 Q4 | 134.1 Million CNY | -6.8% |
| 2014 FY | 134.1 Million CNY | 82.01% |
| 2014 Q3 | 143.89 Million CNY | 0.0% |
| 2013 FY | 73.67 Million CNY | 288.95% |
| 2012 FY | -38.99 Million CNY | 59.62% |
| 2011 FY | -96.55 Million CNY | 0.0% |